Cabaletta Bio, Inc. (CABA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -42.56M | -35.34M | -34.51M | -30.43M | -30.8M | -23.12M | -20.32M | -20.79M | -23.99M | -16.45M | -12.6M | -11.89M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -38.18% | -52.85% | -69.8% | -46.36% | -28.41% | -40.58% | -61.24% | -74.86% | -90.26% | -35.59% | -27.13% | -3.15% |
| Net Income | -43.52M | -41.92M | -44.87M | -45.13M | -35.94M | -32.59M | -30.63M | -27.6M | -25.05M | -20.89M | -16.45M | -14.49M |
| Depreciation & Amortization | 337K | 348K | 345K | 468K | 485K | 468K | 424K | 426K | 393K | 336K | 355K | 833K |
| Stock-Based Compensation | 0 | 4.26M | 5.82M | 5.71M | 5.16M | 5.41M | 5.25M | 5.01M | 3.79M | 3.05M | 3.01M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.21M | 0 | 0 |
| Other Non-Cash Items | 9.99M | 3.58M | 3.98M | 4.46M | 2.54M | 711K | 1.73M | 1.41M | 1M | 3.6M | -68K | 2.72M |
| Working Capital Changes | -9.37M | -1.61M | 215K | 4.07M | -3.05M | 2.87M | 2.9M | -31K | -4.13M | 654K | 548K | -959K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -269K | -1.71M | 1.07M | 595K | 1.59M | 2.7M | -2.01M | -1.34M | 1.66M | 518K | 1.3M | -1.87M |
| Cash from Investing | 50.96M | 49.8M | -50.08M | -49.2M | -785K | 12.12M | 12.25M | 23.73M | -812K | 1.14M | -65K | -48.14M |
| Capital Expenditures | 0 | -205K | -78K | -161K | -785K | -376K | -253K | -770K | -812K | -185K | -65K | -57K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.32K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.32K | 0 | 0 |
| Cash from Financing | 25.27M | 8.33M | -806K | 93.37M | -552K | 4.37M | 71K | 379K | 6.86M | 93.05M | 98K | 94.26M |
| Debt Issued (Net) | -4.27M | 4.35M | -795K | -3M | -552K | -897K | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 29.54M | 10.24M | -25K | 96.18M | 0 | 5.27M | 5.82M | 379K | 5.75M | 91.74M | -141K | 94.03M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -6.26M | 14K | 197K | 0 | 0 | -5.75M | 0 | 1.11M | 1.31M | 239K | 232K |
| Net Change in Cash | 33.65M | 22.78M | -85.41M | 13.78M | -32.13M | -6.65M | -8.01M | 3.32M | -17.95M | 77.74M | -12.57M | 34.23M |
| Free Cash Flow | -42.56M | -35.55M | -34.59M | -30.59M | -31.59M | -23.5M | -20.58M | -21.56M | -24.8M | -16.63M | -12.67M | -11.95M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -34.74% | -51.28% | -68.09% | -41.88% | -27.37% | -41.27% | -62.41% | -80.47% | -90.95% | -33.63% | -15.11% | 3.85% |
| FCF per Share | -0.38 | -0.35 | -0.34 | -0.49 | -0.64 | -0.47 | -0.42 | -0.44 | -0.50 | -0.37 | -0.29 | -0.30 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.84x | 0.77x | 0.67x | 0.86x | 0.71x | 0.66x | 0.75x | 0.96x | 0.79x | 0.77x | 0.82x |
| Interest Paid | 0 | -1.45M | 684K | 557K | 208K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |